| Literature DB >> 26966468 |
Amirchaghmaghi Maryam1, Pakfetrat Atessa1, Mosannen Mozafari Pegah1, Shafiee Zahra2, Ghalavani Hanieh2, Aghasizadeh Davood3, Khazaei Yeganeh4.
Abstract
UNLABELLED: Advances in medical and dental techniques have led to a growing aged population living with complex medical conditions. This study focuses on the detection of medically compromised dental patients by means of a validated patient-administered medical risk-related history questionnaire.Entities:
Keywords: ASA risk; EMRRH; dentistry; medical history.
Year: 2015 PMID: 26966468 PMCID: PMC4765512 DOI: 10.2174/1874210601509010420
Source DB: PubMed Journal: Open Dent J ISSN: 1874-2106
Frequency of medical condition.
| Percentage (%) | Frequency | Medical condition |
|---|---|---|
| 29 | 345 | Taking drug |
| 18 | 214 | Gastrointestinal disorders |
| 17.1 | 203 | Anemia |
| 12 | 142 | antibiotic prophylaxis |
| 11.6 | 138 | Hypertension |
| 9.5 | 113 | chest pain |
| 9.2 | 109 | Heart palpitation without exterior |
| 2.2 | 26 | Heart attack |
| 1.2 | 14 | Heart murmur |
| 7.7 | 91 | Tobacco use |
| 6.9 | 82 | History of allergy |
| 6 | 71 | Received blood products |
| 5.6 | 67 | Diabetes |
| 5.6 | 67 | Bleeding |
| 4.6 | 55 | Pulmonary disease |
| 4.5 | 54 | Thyroid |
| 3.8 | 45 | Renal disease |
| 3.4 | 40 | asthma |
| 2.3 | 28 | Liver diseases |
| 0.75 | 9 | Cancer- leukemia |
| 0.5 | 6 | Heart failure |
| 0 | 0 | hemophilia |
Medical problems measured by the MRRH and their ASA risk scores.
| Medical problems | Diabetes | Thyroid disease | kidney disease | liver disease | Cancer leukemia | hyperventilation | Faint | Drug medication | prophylaxis | pregnancy | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASAI | 1121 (94.4%) | 1134 (95.5%) | 1143 (96.2%) | 1160 (97.6%) | 1179 (99.2%) | 1177 (99.1%) | 1166 (98.1%) | 879 (74%) | 1046 (88%) | 1166 (98.1%) | ||||||||||||
| ASAII | 56 (4.7%) | 9 (0.8%) | 30 (2.5%) | 28 (2.4%) | 5 (0.4%) | 11 (0.9%) | 22 (1.9%) | 345 (26%) | 142 (12%) | 22 (1.9%) | ||||||||||||
| ASAIII | 11 (0.9%) | 37 (3.1%) | 11 (0.9%) | - | 2 (0.2%) | - | - | - | - | |||||||||||||
| ASAIV | - | 8 (0.7%) | 4 (0.3%) | - | 2 (0.2%) | - | - | - | - | |||||||||||||
| ASAI | 1075 (90.5) | 1162 (97.8) | 1174 (98.8) | 1079 (90.8) | 1182 (99.5) | 1050 (88.4) | 1121 (94.4) | 1162 (97.8) | 1148 (96.6) | 1133 (95.4) | 1106 (193) | |||||||||||
| ASAII | 30 (2.5) | 5 (0.4) | 8 (0.7) | 44 (3.7) | 1 (0.1) | 138 (11.6) | 16 (1.3) | 21 (1.8) | 7 (0.6) | 21 (1.8) | 66 (5.6) | |||||||||||
| ASAIII | 42 (3.5) | 12 (1) | 1 (0.1) | 24 (2) | 4 (0.3) | - | 14 (1.2) | - | 25 (2.1) | 8 (0.7) | 14 (1.2) | |||||||||||
| ASAIV | 41 (3.5) | 9 (0.8) | 5 (0.4) | 41 (3.5) | 1 (0.1) | - | 36 (3) | 5 (0.4) | 8 (0.7) | 26 (2.2) | 2 (0.2) | |||||||||||